PENG Block vs FNB + ONB in Patients Undergoing Hip Fracture Surgery With Contraindications to Neuraxial Anesthesia

Pain, Postoperative Clinical Trial

— PENG/FNB+ONB  

Official title:

Pericapsular Nerve Group (PENG) Block vs Femoral Nerve Block (FNB) + Obturator Nerve Block (ONB) in Patients Undergoing Hip Fracture Surgery With Contraindications to Neuraxial Anesthesia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06457880
• Other study ID #: Campus Bio-Medico
• Status: Completed
• Phase: N/A
• Start date: January 1, 2022
• Est. completion date: June 1, 2024

Study information

• Verified date: June 2024
• Source: Campus Bio-Medico University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the study is to demonstrate the efficacy of PENG block as the main anesthetic technique to manage perioperative analgesia for hip fracture surgery compared to femoral and obturator nerve block in patients with contraindications to spinal anesthesia.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: June 1, 2024
• Est. primary completion date: January 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients undergo hip surgery

• patients with contraindications at spinal anesthesia

Exclusion Criteria:

• allergy at local anesthetic

• age under 18 or weight under 30

Related Conditions & MeSH terms

• Coagulopathy
• Comorbidities and Coexisting Conditions
• Fractures, Bone
• Hip Fractures
• Pain, Postoperative

Intervention

Procedure:
• PENG BLOCK
Preoperative ultrasound guided PENG block (ropivacaine 0.5 % 20 mL)
• Femoral Nerve Block
Preoperative ultrasound guided femoral nerve block (ropivacaine 0.5 % 15 mL)
• Obturator Nerve Block
Preoperative ultrasound guided obturator nerve block (ropivacaine 0.5 % 5 mL)

Locations

Country	Name	City	State
Italy	Campus Bio Medico	Roma

Sponsors (1)

Lead Sponsor	Collaborator
Campus Bio-Medico University

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	preoperative pain	Preoperative pain score expressed by numerical rating scale 0-10	30 minutes
Primary	Pain following regional anesthesia	Preoperative pain score following regional anesthesia execution expressed by numerical rating scale 0-10	30 minutes
Primary	Postoperative pain	Postoperative pain score expressed by a numerical rating scale 0-10	24 hours
Secondary	Morphine milligrams (mg) consumption	needed opioid rescue therapy	24 hours